ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 89 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $354 | -25.5% | 325 | 0.0% | 0.00% | – |
| Q4 2022 | $475 | -52.5% | 325 | +91.2% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 170 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 170 | +70.0% | 0.00% | – |
| Q1 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 100 | -39.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 164 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 164 | +64.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -66.7% | 100 | -75.0% | 0.00% | -100.0% |
| Q3 2016 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |